Revolution Medicines, Inc. is 1.7x more valuable than Moderna, Inc. by market capitalization ($30.65 B vs $18.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | MRNA | RVMD |
|---|---|---|
| Market cap | $18.25 B | $30.65 B |
| US-listed rank | #650 | #454 |
| Revenue (latest FY) | $1.94B | $0.00 |
| Net income (latest FY) | -$2.82B | -$1.13B |
| Net margin | -145.2% | - |
| SEC filings | 1,447 | 782 |
Revolution Medicines, Inc. is 1.7x more valuable than Moderna, Inc. by market capitalization ($30.65 B vs $18.25 B).
In their latest fiscal years, Moderna, Inc. reported $1.94B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Moderna, Inc. and Revolution Medicines, Inc., or browse the full rankings.